A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
conditions
Όροι
Última atualização: 2017-04-06
Frequência de uso: 13
Qualidade:
conditions.
■ν,::..,/.,,
Última atualização: 2014-02-06
Frequência de uso: 2
Qualidade:
(:) conditions
Φ οι τη τέ
Última atualização: 2014-02-06
Frequência de uso: 1
Qualidade:
pathophysiological considerations
ΠΑΘΟΦΥΣΙΟΛΟΓΙΚΑ ΔΕΔΟΜΕΝΑ
Última atualização: 2014-02-06
Frequência de uso: 2
Qualidade:
no pathophysiological mechanism has been identified to explain this finding, and no consistent pattern for cause of death observed.
∆εν έχει αναγνωρισθεί κανένας παθοφυσιολογικός µηχανισµός που να εξηγεί αυτό το εύρηµα και δεν παρατηρήθηκε κανένα σύνηθες αίτιο θανάτου.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
radiation dose to specific organs, which may not be the target organ of therapy, may be influenced significantly by pathophysiological changes induced by the disease process.
Η δόση ακτινοβολίας σε ειδικά όργανα, τα οποία ενδέχεται να μην είναι το όργανο-στόχος της θεραπείας, μπορεί να επηρεασθεί σημαντικά από παθοφυσιολογικές αλλαγές που προκαλούνται από την εξέλιξη της νόσου.
Última atualização: 2017-04-26
Frequência de uso: 4
Qualidade:
high doses fed over lifespan result in caecal enlargement and renal pelvic nephrocalcinosis, effects also observed with other polyols (see "pathophysiological considerations").
Η χορήγηση υψηλών δόσεων εφ'όρου ζωής συνεπάγεται τη διεύρυνση του τυφλού και την εμφάνιση νεφρο-πυελικής ασβεστίωσης, πράγμα το οποίο έχει παρατηρηθεί και με άλλες πολυαλκοόλες (βλ. "Παθοφυσιολογικά δεδομένα").
Última atualização: 2014-02-06
Frequência de uso: 2
Qualidade:
Aviso: contém formatação HTML invisível
the development of therapies faces three hurdles: the lack of understanding of underlying pathophysiological mechanisms, the lack of support of early phases of clinical development and the lack of opportunity/cost perception from the pharmaceutical industry.
Την ανάπτυξη θεραπειών παρακωλύουν τρεις ανασταλτικοί παράγοντες: η έλλειψη κατανόησης των υποκείμενων παθοφυσιολογικών μηχανισμών, η ελλιπής υποστήριξη των πρώιμων σταδίων της κλινικής ανάπτυξης και η έλλειψη συμφέροντος/αντίληψης του κόστους από τη φαρμακευτική βιομηχανία.
Última atualização: 2017-04-06
Frequência de uso: 1
Qualidade:
condition
Κατάσταση
Última atualização: 2014-11-21
Frequência de uso: 4
Qualidade: